These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27756193)

  • 21. Medication patterns and dosing guidance in pediatric patients supported with intermittent hemodialysis or continuous kidney replacement therapy.
    McKnite AM; Green DJ; Nelson R; Brewer SC; Watt KM
    Pediatr Nephrol; 2024 May; 39(5):1521-1532. PubMed ID: 38051389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.
    Davis SL; Scheetz MH; Bosso JA; Goff DA; Rybak MJ
    Pharmacotherapy; 2013 Dec; 33(12):1256-63. PubMed ID: 23897602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin Dosing Regimen by Monte Carlo Simulation in Patients on Intermittent High-Efficiency Hemodialysis (HEHD).
    Rungprai D; Jaruratanasirikul S; Wongpoowarak W; Pattharachayakul S; Wanakamanee U; Dandecha P; Jitsurong A
    J Med Assoc Thai; 2015 Jun; 98(6):606-15. PubMed ID: 26219166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of therapeutic drug monitoring of vancomycin in patients with chronic hemodialysis
.
    Mahmoud LB; Chaabouni Y; Ghozzi H; Feriani H; Hakim A; Kharrat M; Marrakchi C; Sahnoun Z; Jmaa MB; Zeghal K; Hachicha J
    Clin Nephrol; 2017 Oct; 88(10):198-204. PubMed ID: 28793955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.
    Elyasi S; Khalili H
    Eur J Clin Pharmacol; 2016 Jul; 72(7):777-88. PubMed ID: 27117446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a vancomycin dosing protocol for intensive care unit patients.
    Brinkman I; Verstappen G; Veeger N; Boerma EC; Buter H
    Neth J Med; 2015 May; 73(4):195-8. PubMed ID: 25968297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA; Neudeck BL; Welage LS; Patel JA; Swartz RD
    Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice.
    Elbarbry F
    Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):259-268. PubMed ID: 29260505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.
    Hong J; Krop LC; Johns T; Pai MP
    Pharmacotherapy; 2015 May; 35(5):455-63. PubMed ID: 26011138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
    Barth RH; DeVincenzo N
    Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgery.
    Hafermann MJ; Kiser TH; Lyda C; Fish DN; Barber GR; Wempe MF; Cleveland JC
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1925-30. PubMed ID: 24521953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol versus Nonprotocol Dosing of Vancomycin in Neonates: A Single Center Evaluation of Steady State Trough Levels.
    Schwartz ML; Wrobel J; Huntley J; Zeilmann C
    Am J Perinatol; 2016 Jun; 33(7):678-82. PubMed ID: 26862722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inadequate antibiotic dosing in patients receiving sustained low efficiency dialysis.
    Keough LA; Krauss A; Hudson JQ
    Int J Clin Pharm; 2018 Oct; 40(5):1250-1256. PubMed ID: 30051232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of vancomycin and gentamicin dialysis clearance using in vivo and in vitro systems.
    Pinner NA; Canada RB; Broyles JE; Hudson JQ
    Ren Fail; 2012; 34(6):703-7. PubMed ID: 22463708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.
    Morrill HJ; Caffrey AR; Noh E; LaPlante KL
    Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.